TMPRSS2 and lung carcinoma: Lung cancer patients with lower TMPRSS2 expression exhibited poor overall survival (OS), postprogression survival (PPS) and first-progression survival (FPS) according to the Kaplan–Meier plotter database (Figure 3A).